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ABSTRACT




Each day, thousands of dogs are brought to animal shelters all over the world, where the majority is euthanized due to overpopulation (Chan et al. 2009, Popa, Clifton & Steiner 2008). In recent years, this population has not declined, but just increases (Harris 2012, Panda, Thakur & Katoch 2008). One possible solution to this problem is to interfere with the reproduction of stray dogs by means of a cheap, fast and animal-friendly method. Chemical castration offers us the means of achieving this. However, a non-surgical method to neuter male and female dogs for more than twelve months does still not exist (Miller, Zawistowski 2013). Fortunately, the discovery of kisspeptin and its antagonist gives us opportunities to find a new non-surgical castration method. 
Kisspeptins (KP), a family of neuropeptides encoded by the gene KISS1, were discovered in 1996 and have recently emerged as essential regulators of gonadotropin-releasing hormone (GnRH) neurons across mammalian species (Irwig et al. 2004, Oakley, Clifton & Steiner 2009). The KISS1 gene encodes for a hydrophobic 145 amino acid secretory polypeptide. This 145 amino acid protein (KP145), depending on the species (d'Anglemont de Tassigny, Colledge 2010), can be cleaved into a smaller 54 amino acid protein (52 in rodents) and from this larger peptide the smaller peptides KP14, KP13 and KP10 are processed (Irwig et al. 2004, Gottsch, Clifton & Steiner 2009, Ohtaki et al. 2001, Lee et al. 1996). It is unclear how these shorter peptides are processed from the larger peptide (Ohtaki et al. 2001). KP10 has full intrinsic biological activity and is the minimal sequence required for full receptor binding and activation (Roseweir et al. 2009, Millar et al. 2010). The G-protein coupled receptor of kisspeptin (GPR54), encoded by the KISS1R gene, has been located on GnRH neurons (Popa, Clifton & Steiner 2008). Kisspeptin stimulates GnRH secretion by binding on this receptor which in turn stimulates the pituitary to secrete luteinizing hormone (LH) and follicle-stimulating hormone (FSH) which is associated with the initiation of reproductive function (Thompson et al. 2004). Kisspeptins are also involved in the regulation of the hypothalamic-pituitary-gonadal (HPG) axis by positive and negative feedback mechanisms (Oakley, Clifton & Steiner 2009). Expression of KISS1 and KISS1R genes increases during pubertal development and inactivating or loss-of-function mutations in respectively KISS1 or KISS1R, demonstrated in humans and mice, cause hypogonadotropic hypogonadism (HH) and impairment of pubertal development (d'Anglemont de Tassigny, Colledge 2010, de Roux et al. 2003, Silveira et al. 2010). Furthermore, administration of a potent kisspeptin antagonist, p234, prevented the post-castration rise of LH in rats, mice and sheep and the preovulatory LH surge in rats (Roseweir et al. 2009, Pineda et al. 2010). Therefore kisspeptin seems to be a key player in puberty onset and maintenance of normal reproductive function in several mammalian species. However, the role of kisspeptin and its receptor in the dog are hardly studied. Recently, Albers-Wolthers et al. (2013) showed that the KISS1 and the KISS1R genes are present in the canine genome and that both human kisspeptin-10 (hKP10) as canine kisspeptin-10 (cKP10) administration (1, 5, 10, 30, 50 and 100 μg/kg BW) in the dog results in a significant increase of the plasma LH concentration at 10 minutes after administration. This study strongly suggests that kisspeptin regulation and GPR54 signaling plays an important role in reproductive function in the dog, as it does in many other species. However, there is no literature about the antagonist p234 in dogs. P234 was developed by Roseweir et al. (2009) via amino acid substitution of kisspeptin-10 analogs and has the ability to block the effects of KP in vivo and in vitro. P234 has the same C-terminal sequence (RF-NH2) as KP10, which is essential for receptor binding. Pineda et al. (2010) used the addition of a penetratin tag to p234 to increase its penetration of the blood-brain-barrier. This tag did not affect the binding affinity of p234 to GPR54 and can be used when p234 is administered peripherally (Pineda et al. 2010). P234 suppresses pulsatile LH secretion in female rats and GnRH release in female monkeys and reduces FSH responses after administration of 100 pmol KP10 in male rats (Pineda et al. 2010, Li et al. 2009, Guerriero et al. 2012). Therefore, p234 seems to have high binding affinity, specificity and efficacy. In practice, p234 might be developed into a contraceptive. Before this antagonist can be used for clinical application, further research is necessary. P234 is probably a competitive antagonist. To determine the effect of p234 on hormone levels after kisspeptin administration in the dog, p234 must be administered in higher doses than the doses of administered kisspeptin, because the antagonist has to be able to compete with kisspeptin. Therefore, before this antagonist is tested in dogs, it would be convenient to determine the dose response relationship between cKP10 and plasma LH concentration in the dog to find the lowest effective dose of cKP10 that still gives a significant rise in plasma LH levels. 




Six healthy Beagle bitches (1-7 years of age) were used in this study. The dogs were born and raised at the Department of Clinical Sciences of Companion Animals and were accustomed to the laboratory environment and procedures, such as blood collection. They were housed in pairs in indoor–outdoor runs and fed a standard commercial dog food once daily. Water was available ad libitum.




In vivo experimental design and collection of blood samples 
A single injection of cKP10 (0.1, 0.5, 1 and 10 μg/kg BW) was given into the vena cephalica to six Beagle bitches during anestrus at weekly intervals. Blood samples were collected from the jugular vein in heparinized tubes at 40 and 0 minutes before cKP10 administration and at 10, 20, 30, 40, 60, 90 and 120 minutes after cKP10 administration. Individual plasma samples were obtained after centrifugation and stored at -20°C until assayed. Before and after each collected blood sample respiratory rate, pulse rate and perfusion indicators (mucous membrane color and capillary refill time) were measured.

Hormone assays
Plasma progesterone concentrations were measured using a 125I-radioimmunoassay (RIA) validated for the dog (Risvanli et al. 2010, Poling, Kauffman 2012, Garcia-Galiano, Pinilla & Tena-Sempere 2012). The intra-assay and interassay coefficients of variation (CVs) were 6% and 10.8%, respectively. The lower limit of quantitation was 0.15 nmol/L. 
Plasma LH concentrations were measured with a heterologous RIA as described previously (Nett et al., 1975). The intra-assay and interassay CVs for values above 0.5 µg/L were 2.3% and 10.5%, respectively, and the limit of quantitation was 0.3 μg/L.

Peptide
cKP10 (YNWNVFGLRY-NH2) was synthesized by American Peptide Company (Sunnyvale, USA) and dissolved in sterile 0.09% NaCl and stored at -20°C. 

Data analysis 
For each dog, basal plasma LH concentrations were calculated as the mean of the values in the samples collected at 40 and 0 minutes before cKP10 administration. The 95 percentile of all plasma LH concentrations at T=-40 and T=0 was determined. Nonparametric test were used, because the plasma LH data were not normally distributed. A Wilcoxon signed rank test and a Friedman test were used to determine differences in plasma LH concentrations before and after cKP10 administration. A Friedman test was used to determine differences between the different doses of cKP10. P < 0.05 was considered statistically significant. Statistical analysis was performed using IBM SPSS for Windows, version 20. 

Ethics of experimentation
The experimental protocol was approved by the Ethics Committee of the Faculty of Veterinary Medicine, Utrecht University, The Netherlands.

In vitro experiments to compare [Ca2+]i response to hKP10 and cKP10 after binding to human GPR54
Chemicals and peptides.      Human KP10 was produced by Eurogentec (Maastricht, The Netherlands) and cKP10 was produced by American Peptide Company (Sunnyvale, USA). Both peptides were dissolved in saline and stored at -20°C. A saline solution, called external medium, was prepared with deionized water (Milli-Q®; resistivity >10 MΩ∙cm) obtained from Millipore (Bedford, MA) and contained (in mM) 125 NaCl, 5.5 KCl, 2 CaCl2, 0.8 MgCl2, 10 HEPES, 24 glucose, and 36.5 sucrose at pH 7.3 (adjusted with NaOH). Ethylenediaminetetraacetic acid (EDTA; 17mM) and stock solutions of 2 mM ionomycin in dimethylsulfoxide (DMSO) were kept at -20°C and thawed before the experiment. NaCl, KCl and HEPES were obtained from Merck (Whitehouse Station, NJ, USA); MgCl2, CaCl2, glucose, sucrose and NaOH were obtained from BDH Laboratory Supplies (Poole, UK). Fura-2 AM was obtained from Molecular Probes (Invitrogen, Breda, The Netherlands). All other chemicals were obtained from Sigma-Aldrich (St. Louis MO, USA), unless otherwise noted. Stock solutions were prepared just prior to the experiments. 
Cell culture.      Chem-1 cells, an adherent cell line, transfected with full-length human GPR54 cDNA were obtained from Millipore (Billerica, MA, USA) and were frozen in liquid nitrogen at 2∙106 cells/ml in DMEM with 20% fetal bovine serum, 100 U/ml penicillin and streptomycin, and 10% DMSO upon receipt. Cell line tests were negative for mycoplasma. After reception, the Chem-1 cells were thawed in a 37°C water bath. After the ice had thawed, the exterior of the vial was sterilized with 70% ethanol and the cells were transferred to a T75 flask containing 20 mL growth medium (Opti-MEM® supplemented with 4% fetal calf serum and 1% glutamine 200 mM) obtained from  Life Technologies (Bleiswijk, The Netherlands) and placed in a humidified 37°C incubator with 5% CO2  for two days to recover. For Ca2+ imaging experiments, the cells were detached with 0.05% Trypsin-EDTA (Life Technologies) and subcultured in 35 mm diameter uncoated glass-bottom dishes (MatTek, Ashland, MA) in 2 mL growth medium at a density of 5 ∙ 105 cells/dish and placed in a 37°C incubator with 5% CO2. Trypsinization was done by first washing the cells with 10 mL Dulbecco’s Phosphate Buffered Saline (DPBS, obtained from Life Technologies) and then incubating the cells with 0.05% trypsin/0.2 g/L EDTA (1 mL/T75) for 5-10 minutes at RT. After incubation, the cells were dislodged by rapping the side of the flask  and the cells were observed under the microscope. When the cells were rounded and loosen they were transferred to a culture tube and growth medium with serum was added to neutralize the trypsin. The cells were centrifuged at 1500-2000 RPM for 15 minutes at ambient temperature and  the supernatant was removed carefully and replaced with fresh medium. The cells were counted in a hemocytometer and transferred to glass-bottom dishes as described above. Ca2+ imaging experiments were performed 1 day after subculture.
Ca2+ imaging.     To measure changes in the intracellular Ca2+ concentration ([Ca2+]i) a Ca2+-sensitive fluorescent ratio dye Fura-2 AM was used. Briefly, cells were incubated with 5 μM Fura-2 AM in external medium for 20 minutes at room temperature (RT), followed by 15 minutes de-esterification in external medium at RT. After de-esterification the cells were placed on the stage of an Axiovert 35M inverted microscope (Zeiss, Göttingen, Germany) equipped with a TILL Photonics Polychrome IV (TILL Photonics GmBH, Gräfelfing, Germany). Fluorescence, evoked by 340 and 380 nm excitation wavelengths (F340 and F380), was collected at 510 nm with an Image SensiCam digital camera (TILL Photonics GmBH). This digital camera and polychromator were controlled by imaging software (TILLvisION, version 4.01), which was also used for data collection and processing. The F340/F380 ratio (R), which is a qualitative measure for [Ca2+]i, was collected every 6 seconds. Changes in R were further analyzed using custom-made MS-Excel macros and included background correction. The recording of each experiment lasted 45 minutes. After 5 minutes baseline recording with external medium, cells were exposed to hKP10 (10-6,10-8 or 10-10 M) or cKP10 (10-6,10-8 or 10-10 M) for 18 seconds. At the end of the recording maximum and minimum ratios (Rmax and Rmin) were determined by addition of 5μM ionomycin and 17 mM EDTA respectively as a control for the experimental conditions.
Data analysis and Statistics     All data are presented as mean [Ca2+]i ± standard error of the mean (SEM) from the number of cells (n) indicated, obtained from 1-3 independent experiments (N) per dose. For each cell, basal intracellular calcium concentrations were calculated as the mean over the first 5 minutes. Furthermore, the maximum amplitude of  [Ca2+]i after KP10 exposure was calculated. To determine whether all basal[Ca2+]i were equal, a one-way ANOVA was used. A Paired Samples T-test was used to determine differences between basal [Ca2+]i and the maximum amplitude of [Ca2+]i after KP10 exposure for both hKP10 and cKP10. For each dose, an Independent Samples T-test was used to determine differences in the maximum amplitude of [Ca2+]i after hKP10 and cKP10 exposure. Furthermore, for both hKP10 and cKP10, a one-way ANOVA was performed to determine differences in the maximum amplitude of [Ca2+]i between doses. Significant main effects were followed up by Bonferroni corrected pairwise comparisons. P < 0.05 was considered statistically significant. Statistical analysis was performed using IBM SPSS for Windows, version 20. 

RESULTS
In vivo dose-response study with cKP10
The 95 percentile of all plasma LH concentrations at T=-40 and T=0 was 3.88. A Wilcoxon signed rank test indicated that administration of all different doses of cKP10 resulted in a significant increase of the plasma LH concentration at T=10 (Table 1A and Figure 1). A Friedman test indicated that there was no significant difference in plasma LH concentrations between all the moments before and after 0.1 μg/kg BW cKP10 administration. Plasma LH concentrations at 10 minutes after 0.1 μg/kg BW cKP10 administration were significantly lower compared to the plasma LH concentrations at 10 minutes after 0.5, 1, and 10 μg/kg BW cKP10 administration (P=0.03). The plasma LH concentrations at T=10 did not differ significantly between 0.5, 1, and 10 μg/kg BW cKP10 (Table 1B). For 0.5, 1 and 10 μg/kg BW cKP10 plasma LH concentrations at T=10 were significantly higher than plasma LH concentrations at 20, 30, 40, 60, 90 and 120 minutes after cKP10 administration (P=0.02). For 0.1 μg/kg BW cKP10 the plasma LH concentration at T=10 was significantly higher than the plasma LH concentration at T=30 (P=0.03). After 0.1 μg/kg BW cKP10 administration basal LH levels were reached again at T=20, after 1 μg/kg at T=90 and after 0.5 μg/kg and 10 μg/kg BW cKP10 administration at T=120. The median plasma LH concentrations at T=10 after administration of 0.5, 1, and 10 μg/kg BW cKP10 were higher than the 95 percentile of the measured basal plasma LH concentrations (Figure 2). The median plasma LH concentrations at T=10 after administration of 0.5, 1 and 10 μg/kg BW cKP10 (14.3 μg/L) were 6.5 times larger than the median basal plasma LH concentration (2.2 μg/L). For 0.1 μg/kg BW cKP10 this median plasma LH concentration (3.0 μg/L) was 1.3 times larger than the median basal plasma LH concentration (2.3 μg/L) and was lower than the 95 percentile of the measured basal plasma LH concentrations. Respiratory rate, pulse rate and perfusion indicators remained stable in all dogs throughout the experimental period (data not shown).

In vitro Ca2+ imaging experiments with hKP10 and cKP10
One of the results is presented in Figure 3 as a typical example of the [Ca2+]i. For each dose, the results of one experiment are presented in Figure 4. A one-way ANOVA indicated that there were significant differences between the basal [Ca2+]i (F (5,146) = 8.74, P < 0.001). For all doses, the maximum amplitude of [Ca2+]i was significantly higher compared to the basal [Ca2+]i after hKP10 and cKP10 exposure (P < 0.001)(Table 2A). The maximum amplitude of [Ca2+]i after hKP10 exposure was significantly different from cKP10 exposure only for the 10-8 M dose (P < 0.001, 95% CI [-1737 -749])(Table 2B). Significant differences between doses were only found after cKP10 exposure (Table 2C); the 10-10 M dose differed significantly from both the 10-6 M and 10-8 M dose (P < 0.001, 95% CI [-1337 -451] and [-1981 -808] respectively). 

DISCUSSION
In vivo dose-response study
The purpose of this study was to investigate the minimal dose of intravenously administered cKP10 in adult female dogs in anestrus that results in a significant LH  response above the 95 percentile of the measured basal plasma LH concentrations. One dog (0.1 μg/kg BW cKP10) had a basal plasma LH concentration that exceeded this 95 percentile, probably due to pulsatile LH secretion, and was excluded from the statistical analysis. The results showed that a statistically significant increase in plasma LH concentrations was reached at 10 minutes after administration of all doses of cKP10. These findings explain that all doses are effective, while the lowest dose is 10 times lower than the lowest doses used in the study of Albers-Wolthers et al. (2013). However, a Friedman test indicated that there was no significant difference in plasma LH concentrations between all blood samples collected before and after 0.1 μg/kg BW cKP10 administration. Furthermore, there was a significant difference in plasma LH concentrations at 10 minutes after cKP10 administration between 0.1 μg/kg BW cKP10 and the three highest doses of cKP10 and the median plasma LH concentration at T=10 after 0.1 μg/kg BW cKP10 administration was 1.3 times larger than the median basal plasma LH concentration. For the other doses this was 6.5 times larger. 0.1 μg/kg BW cKP10 administration did not result in an increase above the 95 percentile of the measured basal plasma LH concentrations. According to these data we suggest that 0.5 μg/kg BW cKP10 (i.v. administration) is more effective than 0.1 μg/kg BW cKP10 and is the lowest dose that gives an increase in plasma LH concentrations above the 95 percentile of the measured basal plasma LH concentrations. In men the peripherally administered lowest effective dose was 0.1 μg/kg BW hKP10, in ovariectomized cows 0.13 μg/kg BW hKP10 and in ewes 0.16 μg/kg BW hKP10 (George et al. 2011, Whitlock et al. 2008, Caraty et al. 2007). In male rats, goats, prepubertal heifers, calves, prepubertal gilts and monkeys the lowest peripherally administered doses were respectively 0.39, 1, 4.8, 5, 13.4-16.6 and 25.6-34.5 μg/kg hKP10 and were all effective ( Tovar et al. 2006, Hashizume et al. 2010, Ezzat Ahmed et al. 2009, Shahab et al. 2005, Kadokawa et al. 2008, Lents et al. 2008). However, only George et al. (2011),  Whitlock et al. (2008) and Caraty et al. (2007) did a dose-response study with lower non-effective doses. Therefore, in the other mammals lower doses may also be effective. 
There was no significant difference in plasma LH concentrations at T=10 after cKP10 administration between the three highest doses of cKP10, which suggests that a maximum LH response had been reached after administration of 0.5 μg/kg BW. cKP10. Furthermore, Albers-Wolthers et al. (2013) showed that there was no significant difference in plasma LH concentrations at T=10 after cKP10 administration between all the doses (1-100 μg/kg). This does not support a dose-dependent increase in plasma LH concentrations in response to cKP10 administration in the dog. However, analysis of Figure 1 and 2 suggest that there is a dose-dependent increase in plasma LH concentrations in response to cKP10 administration. Furthermore, Albers-Wolthers et al. (2013) showed that the median increase in plasma LH concentration after administration of higher doses of cKP10 (1, 5, 10, 30, 50 and 100 μg/kg) was slightly more than 10-fold, while the median increase after 0.5, 1 and 10 μg/kg BW cKP10 was 6.5-fold. Plasma LH concentrations due to pulsatile LH secretion in Beagle bitches in anestrus can be 10- to 20-fold higher than basal plasma LH concentrations (Kooistra et al. 1999, Beijerink et al. 2007). George et al. (2011) showed a dose-dependent rise in serum LH concentration in men. However, before this can be concluded in dogs, more research is necessary and doses between 0.1 and 0.5 μg/kg BW cKP10 must be administered to dogs in anestrus to determine the rise in plasma LH concentrations.

In vitro Ca2+ imaging experiments
The purpose of this study was to compare the [Ca2+]i response to hKP10 and cKP10 after binding to the human kisspeptin receptor GPR54 in vitro. The results showed that there were significant differences between the basal [Ca2+]i for both hKP10 and cKP10. This can be due to differences in the experimental setup between experiments. For example differences in the homogeneity of the cells, in room temperature, in the flow of external medium over the cells and in time of incubation of the cells with Fura-2 AM. Based on these results, the significant differences between maximum [Ca2+]i amplitudes are less reliable and the interpretation is more difficult. To get more reliable results, the experimental setup must be the same between different experiments and for each dose more experiments must be performed. When there are no significant differences between maximum amplitudes of [Ca2+]i for different doses, there can be significant differences in [Ca2+]i after the amplitude. It is possible that a high dose of KP10 is toxic or harmful to a cell. The cell will react on KP10 exposure, but will not return to basal [Ca2+]i or the cell will oscillate. In a figure as Figure 3 this toxic effect can be seen as a messy image where the lines lie further upwards after the maximum amplitude and are not perfectly horizontal, but show random peaks. In Figure 4 this toxic effect can be seen after exposure of 10-6 and 10-8 hKP10 and cKP10 to the cells.

Conclusions
In this study we have conclusively demonstrated that 0.5 μg/kg BW cKP10 is the lowest dose that significantly increases the plasma LH concentration above the 95 percentile of the measured basal plasma LH concentrations in the dog and that hKP10 and cKP10 give a similar [Ca2+]i response after binding to the human kisspeptin receptor GPR54 in vitro. 


Fig. 1. Median plasma LH concentrations in response to intravenous administration of 0.1, 0.5, 1 and 10 μg/kg BW cKP10 (T=0) to Beagle bitches (n=5 for 0.1 μg/kg; n=6 for 0.5, 1 and 10 μg/kg). 


Fig. 2. Boxplots of LH concentrations 10 minutes after 0.1, 0.5, 1 and 10 μg/kg BW cKP10 administration to Beagle bitches (n=5 for 0.1 μg/kg; n=6 for 0.5, 1 and 10 μg/kg). The horizontal line corresponds with the 95 percentile of all plasma LH concentrations at T=-40 and T=0 (3.88). 


Fig. 3. [Ca2+]i before and after 10-10 hKP10 exposure. The mean [Ca2+]i over the first 5 minutes was taken as the basal value and the maximum amplitude of [Ca2+]i after KP10 exposure was calculated for each dose.


Fig. 4. F340/F380 ratio (R) before and after KP10 exposure.


Table 1. Exact Significances (1-tailed). A. Wilcoxon signed rank test. B. Friedman test. 
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